Sabs Pharmaceutical Private Limited
About Sabs Pharmaceutical Private Limited
Data last updated:
Sabs Pharmaceutical Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 January 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U74120UP2015PTC068019. Its GSTIN is 09AAVCS3371E1ZX (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sunil Singh and Ashutosh Verma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 9 Rahim Nagar Daudooli Sitapur Road, Lucknow, Uttar Pradesh, India – 226021.
As per the financials filed for FY 2024, the company reported a revenue of ₹7.58 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1,179 (net margin 0.2%) and EBITDA of ₹1,179 (EBITDA margin 0.2%). Revenue has grown at a compounded annual rate (CAGR) of 13% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sabs Pharmaceutical Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No. 9 Rahim Nagar Daudooli Sitapur Road, Lucknow, Uttar Pradesh, India – 226021
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sabs Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sabs Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sabs Pharmaceutical Private Limited, buy the company report.
Financials of Sabs Pharmaceutical Private Limited
FY 2025 filings availableSabs Pharmaceutical Private Limited reported revenue of ₹7.58 Lakh (up 209% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 209% growth in the latest year. EBITDA rose 105% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1,179 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,179 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sabs Pharmaceutical Private Limited, buy the company report.
Board of directors of Sabs Pharmaceutical Private Limited
Sabs Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Singh | Director | 06 Jan 2015 | 11 Years 10 Months | Current |
| Ashutosh Verma | Director | 06 Jan 2015 | 11 Years 10 Months | Current |
Peer comparison
Sabs Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Genuine Tradecom Private Limited | ₹7.59 Lakh (FY 2025) | -2.0% | Kolkata, West Bengal, India | |||
| Umananda Jute Mills (I) Limited | ₹7.59 Lakh (FY 2022) | 18.0% | Hooghly, West Bengal, India | |||
| Thulliyam (OPC) Private Limited | ₹7.58 Lakh (FY 2020) | 268.0% | Salem, Tamil Nadu, India | |||
| Sante Healthcare Private Limited | ₹7.58 Lakh (FY 2021) | Bengaluru, Karnataka, India | ||||
| Mandal Projects Private Limited | ₹7.58 Lakh (FY 2025) | 17.0% | Kolkata, West Bengal, India | |||
| Sabs Pharmaceutical Private Limitedthis company | ₹7.58 Lakh (FY 2024) | ₹1,179 | 0.2% | 209.0% | Lucknow, Uttar Pradesh, India | |
| Harajuku Import Export Private Limited | ₹7.58 Lakh (FY 2024) | Delhi, India | ||||
| Inderjeet Shanti Foundation | ₹7.58 Lakh (FY 2025) | 38.0% | Bettiah, Bihar, India | |||
| Sunray Enterprises Private Limited | ₹7.58 Lakh (FY 2025) | 63.0% | Ernakualm, Kerala, India | |||
| Venkatapathi Food Processors and Manufacturers Private Limited | ₹7.58 Lakh (FY 2021) | Metpally, Telangana, India | ||||
| Siddhi Retails Private Limited | ₹7.58 Lakh (FY 2018) | 1932.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Sabs Pharmaceutical Private Limited, buy the company report.
Shareholding
The shareholding of Sabs Pharmaceutical Private Limited is on record for FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2016 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Sabs Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sabs Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sabs Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sabs Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAVCS3371E1ZX | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sabs Pharmaceutical Private Limited, buy the company report.
Recent activity
Sabs Pharmaceutical Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Suraj Kumar Singh ceased to be Director on 17 May 2023.
Frequently asked questions
Sabs Pharmaceutical is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 January 2015 (11+ years old) and is registered under CIN U74120UP2015PTC068019.
Sabs Pharmaceutical has 2 current directors:
- Sunil Singh - Director
- Ashutosh Verma - Director
The latest financial statements of Sabs Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sabs Pharmaceutical is 09AAVCS3371E1ZX, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Sabs Pharmaceutical is U74120UP2015PTC068019. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sabs Pharmaceutical was incorporated on 06 January 2015, making it 11+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Sabs Pharmaceutical by revenue are Genuine Tradecom Private Limited, Umananda Jute Mills (I) Limited, Thulliyam (OPC) Private Limited, Sante Healthcare Private Limited, Mandal Projects Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Suraj Kumar Singh ceased to be Director on 17 May 2023. Beerendra Pratap Singh ceased to be Director on 24 Dec 2015. Ashutosh Verma was appointed as Director on 06 Jan 2015. Sabs Pharmaceutical has 4 board changes on record in total.
The registered office of Sabs Pharmaceutical is at Plot No. 9 Rahim Nagar Daudooli Sitapur Road, Lucknow, Uttar Pradesh, India – 226021.
Sabs Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Sabs Pharmaceutical is compliant as of 03 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
